Related Experiment Video
Updated: Feb 21, 2026
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
How activating mutations affect MEK1 regulation and function
Granton A Jindal1,2,3, Yogesh Goyal1,2,3, John M Humphreys4
1From the Departments of Chemical and Biological Engineering and.
Abstract:
The MEK1 kinase directly phosphorylates ERK2, after the activation loop of MEK1 is itself phosphorylated by Raf. Studies over the past decade have revealed a large number of disease-related mutations in the MEK1 gene that lead to tumorigenesis and abnormal development. Several of these mutations result in MEK1 constitutive activity, but how they affect MEK1 regulation and function remains largely unknown. Here, we address these questions focusing on two pathogenic variants of the Phe-53 residue, which maps to the well-characterized negative regulatory region of MEK1. We found that these variants are phosphorylated by Raf faster than the wild-type enzyme, and this phosphorylation further increases their enzymatic activity. However, the maximal activities of fully phosphorylated wild-type and mutant enzymes are indistinguishable. On the basis of available structural information, we propose that the activating substitutions destabilize the inactive conformation of MEK1, resulting in its constitutive activity and making it more prone to Raf-mediated phosphorylation. Experiments in zebrafish revealed that the effects of activating variants on embryonic development reflect the joint control of the negative regulatory region and activating phosphorylation. Our results underscore the complexity of the effects of activating mutations on signaling systems, even at the level of a single protein.
Insights
Mutations in the MEK1 gene can cause cancer by altering protein regulation. This study reveals how specific MEK1 variants become constitutively active, impacting cell signaling and development.
Area of Science:
- Molecular Biology
- Cell Signaling
- Genetics
Background:
- The MEK1 kinase is a key component of the MAPK/ERK pathway, regulating cell growth and differentiation.
- Disease-associated MEK1 mutations often lead to constitutive activity, but their regulatory mechanisms are poorly understood.
- The Phe-53 residue in MEK1's negative regulatory region is implicated in disease pathogenesis.
Purpose of the Study:
- To investigate the impact of Phe-53 MEK1 variants on kinase regulation and function.
- To elucidate the mechanisms underlying MEK1 constitutive activity caused by pathogenic mutations.
- To understand the developmental consequences of MEK1 activating mutations in vivo.
Main Methods:
- Site-directed mutagenesis to create Phe-53 MEK1 variants.
- In vitro kinase assays to measure MEK1 activity and phosphorylation by Raf.
- Structural analysis to propose mechanisms of altered MEK1 conformation.
- Zebrafish (Danio rerio) models to assess developmental effects.
Main Results:
- Phe-53 MEK1 variants exhibit accelerated Raf-mediated phosphorylation compared to wild-type.
- This enhanced phosphorylation further boosts the enzymatic activity of the variants.
- Maximal activities of fully phosphorylated wild-type and mutant MEK1 are comparable.
- Activating substitutions appear to destabilize MEK1's inactive conformation, promoting constitutive activity.
- Zebrafish studies demonstrate that variant effects on development involve interplay between the negative regulatory region and activating phosphorylation.
Conclusions:
- Pathogenic MEK1 mutations at Phe-53 enhance susceptibility to activating phosphorylation by Raf.
- These mutations likely destabilize the inactive MEK1 conformation, leading to constitutive signaling.
- The developmental impact of MEK1 variants results from combined effects of altered negative regulation and phosphorylation.
- Understanding these complex regulatory mechanisms is crucial for targeting MEK1 in diseases like cancer.
Related Concept Videos
01:07MAPK Signaling Cascades
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:38Mitogens and the Cell Cycle
01:22PI3K/mTOR/AKT Signaling Pathway
02:23Abnormal Proliferation
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...